In the latest trading session, Pfizer (PFE) closed at $22.15 ... these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this ...

The market seems to be waking up on Pfizer's recovery prospects ... particularly evidenced by its recent quarter performance - I think that the stock should continue to be rated as a "Buy".

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Pfizer (PFE) closed at $29.74 in the latest ... these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a ...

The remarkable improvement was driven by the strong performance of Pfizer's core portfolio ... and then choose between a market order or a limit order to buy the stock. To sell shares of Pfizer ...

Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market ... could be a truer performance indicator. PFE has a P/S ratio ...

The drugmaker's stock has dropped by 15.91% in the past month, falling short of the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%. The investment community will be paying close ...